New Analysis Showed That High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass...
                   
drugs.com     May 22, 2008            

NEW YORK--(BUSINESS WIRE)--May 21, 2008 - Pfizer Inc announced today that Lipitor(R) (atorvastatin calcium) 80 mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27 percent in patients with heart... [read full story]                    


View all news articles about*:
Aid Cardiovascular Care Chest Cholesterol Diet Drugs General Health Hospital Hospitals Medicines Pain Patients Pfizer Pharmaceuticals Remedies Surgery Symptoms
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

Fenofibrate and CoQ may lessen diabetic heart risk

reutershealth.com     8 hrs ago   1 related          

NEW YORK (Reuters Health) - The cholesterol-lowering product fenofibrate in combination with the popular supplement coenzyme Q10, or CoQ, appears to have beneficial effects for people with type 2 diabetes and mildly impaired...                    

comments

                   

Heart Disease

waynebrownministries.com     11 hrs ago   2 related          

http://www.waynebrownministries.com Time-CNN Heart disease is often referred to as the leading cause of death in the U.S. — but in fact, nobody dies of heart disease, because there is no such thing. “Heart disease” is a...                    

comments

                   

Gene Behind Serious Statin Risk

webmd.com     13 hrs ago          

Muscle Condition From Cholesterol Drugs Linked to Gene Variant By Daniel J. DeNoon WebMD Health News Aug. 20, 2008 -- A variant gene causes more than 60% of cases of a serious side effect of cholesterol-lowering statin drugs --...                    

comments

Statins: No Cancer Risk

webmd.com     13 hrs ago   7 related          

Study Shows Cholesterol-Lowering Drugs Not Guilty of Cancer Risk By Daniel J. DeNoon WebMD Health News Aug. 20, 2008 -- Cholesterol-lowering statin drugs do not increase cancer risk, says Tufts University's Richard Karas, MD,...                    

comments